Get the Stockscreener App
368.36
2.41%
-9.11
After Hours:
365.00
-3.36
-0.91%
Beone Medicines Ltd Adr stock is traded at $368.36, with a volume of 452.52K.
It is down -2.41% in the last 24 hours and up +12.64% over the past month.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
See More
Previous Close:
$377.47
Open:
$375.99
24h Volume:
452.52K
Relative Volume:
1.58
Market Cap:
$40.40B
Revenue:
$4.56B
Net Income/Loss:
$-176.77M
P/E Ratio:
-214.45
EPS:
-1.7177
Net Cash Flow:
$225.30M
1W Performance:
+10.83%
1M Performance:
+12.64%
6M Performance:
+63.91%
1Y Performance:
+0.00%
1-Day Range:
$365.52
$381.50
1-Week Range:
$312.87
$381.50
52-Week Range:
$172.67
$381.50
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Name
Beone Medicines Ltd Adr
Sector
Industry
Phone
41-616851900
Address
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Barclays | Overweight |
| Apr-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Mar-03-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-03-24 | Resumed | Morgan Stanley | Overweight |
| Sep-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Feb-06-24 | Resumed | JP Morgan | Overweight |
| Sep-12-23 | Initiated | Macquarie | Outperform |
| Aug-17-23 | Initiated | Jefferies | Buy |
| Jul-17-23 | Initiated | Citigroup | Buy |
| Jun-30-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-12-23 | Initiated | Daiwa Securities | Buy |
| Oct-13-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-13-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-09-22 | Resumed | JP Morgan | Overweight |
| Mar-17-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Feb-07-22 | Initiated | Deutsche Bank | Buy |
| Oct-12-21 | Initiated | Bernstein | Outperform |
| Oct-06-21 | Upgrade | CLSA | Underperform → Buy |
| Mar-08-21 | Initiated | China Renaissance | Buy |
| Mar-01-21 | Downgrade | CLSA | Outperform → Underperform |
| Nov-09-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Nov-06-20 | Downgrade | Maxim Group | Buy → Hold |
| Nov-06-20 | Downgrade | Piper Sandler | Neutral → Underweight |
View All
Beone Medicines Ltd Adr Stock (ONC) Latest News
1,839 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Vestmark Advisory Solutions Inc. - MarketBeat
M&G PLC Invests $41.19 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Greenwoods Asset Management Hong Kong Ltd. Makes New $3.75 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
4,740 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Profund Advisors LLC - MarketBeat
ABC Arbitrage SA Takes $836,000 Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Penserra Capital Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Fox Run Management L.L.C. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Y Intercept Hong Kong Ltd Makes New $564,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
RBC Capital Adjusts Price Target on BeOne Medicines to $395 From $374, Maintains Outperform Rating - 富途牛牛
Envestnet Asset Management Inc. Acquires Shares of 62,220 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
5,362 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by EFG Asset Management North America Corp. - MarketBeat
ETFs Investing in BeOne Medicines Ltd. Sponsored ADR Stocks - TradingView
AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND - Benzinga
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Oppenheimer Asset Management Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Allianz Asset Management GmbH Acquires Shares of 3,300 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
DekaBank Deutsche Girozentrale Purchases Shares of 13,600 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Yousif Capital Management LLC Invests $368,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Sequoia Financial Advisors LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Janney Montgomery Scott LLC Takes $373,000 Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Callan Family Office LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
1,002 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by IFP Advisors Inc - MarketBeat
Free cash flow per share of BeOne Medicines Ltd. Sponsored ADR – DUS:49BA - TradingView
Blue Trust Inc. Buys New Shares in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap DownHere's What Happened - MarketBeat
BeOne Medicines (ONC): Valuation Insight Following Positive Sonrotoclax Trial Results - Sahm
QRG Capital Management Inc. Takes Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
QRG Capital Management Inc. Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Net income before discontinued operations of BeOne Medicines Ltd. Sponsored ADR – BOATS:ONC - TradingView
Operating expenses (excl. COGS) of BeOne Medicines Ltd. Sponsored ADR – BOATS:ONC - TradingView
BeOne Medicines (NASDAQ:ONC) SVP Sells $3,739,118.40 in Stock - MarketBeat
Venturi Wealth Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys Shares of 3,824 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd. Sponsored ADR (ONC) Stock Price Today | Live Chart & News - Traders Union
160 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Acquired by Farther Finance Advisors LLC - Defense World
Slow Capital Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Signaturefd LLC Purchases New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
PFG Investments LLC Acquires Shares of 985 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Reaches New 52-Week HighTime to Buy? - MarketBeat
14,420 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - Defense World
14,420 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - MarketBeat
Perigon Wealth Management LLC Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
LVW Advisors LLC Purchases Shares of 1,022 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Beone Medicines Ltd Adr Stock (ONC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Beone Medicines Ltd Adr Stock (ONC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lee Chan Henry | SVP, General Counsel |
Oct 08 '25 |
Option Exercise |
211.04 |
9,559 |
2,017,363 |
9,559 |
| Lee Chan Henry | SVP, General Counsel |
Oct 08 '25 |
Sale |
350.40 |
10,671 |
3,739,108 |
0 |
1.76%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):